Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCooper, Mark Een
dc.contributor.authorVranes, Den
dc.contributor.authorYoussef, Sen
dc.contributor.authorStacker, S Aen
dc.contributor.authorCox, Allison Jen
dc.contributor.authorRizkalla, Ben
dc.contributor.authorCasley, David Jen
dc.contributor.authorBach, Leon Aen
dc.contributor.authorKelly, D Jen
dc.contributor.authorGilbert, Richard Een
dc.identifier.citationDiabetes; 48(11): 2229-39en
dc.description.abstractIt has been suggested that the cytokine vascular endothelial growth factor (VEGF) has an important role in the pathogenesis of diabetic retinopathy, but its role in nephropathy has not been clearly demonstrated. Assessment of VEGF, 125I-VEGF binding, and vascular endothelial growth factor receptor-2 (VEGFR-2) in the kidney was performed after 3 and 32 weeks of streptozotocin-induced diabetes. Gene expression of both VEGF and VEGFR-2 was assessed by Northern blot analysis and the localization of the ligand and receptor was examined by in situ hybridization. VEGF and VEGFR-2 protein were also evaluated by immunohistochemistry. Binding of the radioligand 125I-VEGF was evaluated by in vitro and in vivo autoradiography. Diabetes was associated with increased renal VEGF gene expression. VEGF mRNA and protein were localized to the visceral epithelial cells of the glomerulus and to distal tubules and collecting ducts in both diabetic and nondiabetic rats. Renal VEGFR-2 mRNA was increased after 3 weeks of diabetes but not in long-term diabetes. In situ hybridization and immunohistochemical studies revealed that glomerular endothelial cells were the major site of VEGFR-2 expression. In addition, VEGFR-2 gene expression was detected in cortical and renomedullary interstitial cells and on endothelial cells of peritubular capillaries. There was an increase in 125I-VEGF binding sites after 3 but not 32 weeks of diabetes. The major VEGF binding sites were in the glomeruli. 125I-VEGF binding was also observed in medullary rays and in the renal papillae. These studies indicate an early and persistent increase in renal VEGF gene expression in association with experimental diabetes. In addition, an early and transient increase in renal VEGF receptors was also observed in diabetic rats. These findings are consistent with a role for VEGF in mediating some of the changes observed in the diabetic kidney.en
dc.subject.otherBlood Glucose.metabolismen
dc.subject.otherBlood Pressureen
dc.subject.otherBlotting, Northernen
dc.subject.otherBody Weighten
dc.subject.otherDiabetes Mellitus, Experimental.genetics.metabolism.physiopathologyen
dc.subject.otherEndothelial Growth Factors.genetics.metabolismen
dc.subject.otherGene Expression Regulationen
dc.subject.otherIn Situ Hybridizationen
dc.subject.otherRNA, Messenger.geneticsen
dc.subject.otherRats, Sprague-Dawleyen
dc.subject.otherReceptor Protein-Tyrosine Kinases.genetics.metabolismen
dc.subject.otherReceptors, Growth Factor.genetics.metabolismen
dc.subject.otherReceptors, Vascular Endothelial Growth Factoren
dc.subject.otherTranscription, Geneticen
dc.subject.otherVascular Endothelial Growth Factor Aen
dc.subject.otherVascular Endothelial Growth Factorsen
dc.titleIncreased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes.en
dc.typeJournal Articleen
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Austin and Repatriation Medical Centre, West Heidelberg, Victoria, Australiaen
dc.type.austinJournal Articleen
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

checked on Jan 27, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.